These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32832130)

  • 1. Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa.
    Roopun KR; Tomita A; Paruk S
    S Afr J Psychiatr; 2020; 26():1509. PubMed ID: 32832130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses.
    Geerts P; Martinez G; Schreiner A
    BMC Psychiatry; 2013 Feb; 13():58. PubMed ID: 23414331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa.
    Veyej N; Moosa MYH
    S Afr J Psychiatr; 2022; 28():1809. PubMed ID: 35812829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
    Stanković Z; Ille T
    Vojnosanit Pregl; 2013 Mar; 70(3):267-73. PubMed ID: 23607237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Long Acting Injectable Antipsychotics with Caregiver Burden, Quality of Life, Symptom Severity and Treatment Discontinuation in Schizophrenia.
    Uysal F; Yildizhan E; Tomruk NB
    Turk Psikiyatri Derg; 2022; 33(3):167-179. PubMed ID: 36148567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
    Patel MX; De Zoysa N; Bernadt M; David A
    J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics: A Retrospective Chart Review and Prescribers' Attitude Survey.
    Misawa F; Amemiya A; Fujii Y; Takeuchi H
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):81-86. PubMed ID: 34668878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis.
    Titus-Lay EN; Ansara ED; Isaacs AN; Ott CA
    Ment Health Clin; 2018 Mar; 8(2):56-62. PubMed ID: 29955546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability.
    Singh SM; Haddad PM; Husain N; Heaney E; Tomenson B; Chaudhry IB
    Ther Adv Psychopharmacol; 2016 Jun; 6(3):162-71. PubMed ID: 27354904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.
    Llorca PM; Abbar M; Courtet P; Guillaume S; Lancrenon S; Samalin L
    BMC Psychiatry; 2013 Dec; 13():340. PubMed ID: 24359031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.
    Das AK; Malik A; Haddad PM
    Ther Adv Psychopharmacol; 2014 Oct; 4(5):179-85. PubMed ID: 25360242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10.
    Tatini L; D'Anna G; Pietrini F; Calligaris E; Ballerini A; Ricca V
    Int Clin Psychopharmacol; 2021 Jul; 36(4):181-187. PubMed ID: 33902086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in attitude towards LAI antipsychotic maintenance treatment: A two-year follow-up study.
    Pietrini F; D'Anna G; Tatini L; Talamba GA; Andrisano C; Calderani E; Manetti M; Rossi Prodi P; Ricca V; Ballerini A
    Eur Psychiatry; 2018 Sep; 53():58-65. PubMed ID: 29957369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAI versus oral: A case-control study on subjective experience of antipsychotic maintenance treatment.
    Pietrini F; Spadafora M; Tatini L; Talamba GA; Andrisano C; Boncompagni G; Manetti M; Ricca V; Ballerini A
    Eur Psychiatry; 2016 Sep; 37():35-42. PubMed ID: 27442981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting injectable antipsychotics in the elderly: guidelines for effective use.
    Masand PS; Gupta S
    Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting.
    Alastanos JN; Paxos C; Emshoff J
    Ment Health Clin; 2019 Jan; 9(1):18-23. PubMed ID: 30627499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.